Stock BIG1 BIO-GATE AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bio-Gate AG

Equities

BIG1

DE000BGAG981

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG
Other stock markets
 16:20:01 03/07/2024 BST 		5-day change 1st Jan Change
0.95 EUR -3.55% Intraday chart for Bio-Gate AG -6.86% -10.38%
05-01 Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6.499 6.499 29.18 20.78 8.908 9.101 - -
Enterprise Value (EV) 1 6.499 6.499 29.18 20.78 8.908 9.101 9.101 9.101
P/E ratio - - - - - - - -
Yield - - - - - - - -
Capitalization / Revenue 1.86 x 1.27 x 4.68 x 3.47 x 1.23 x 1.14 x 1 x 0.87 x
EV / Revenue 1.86 x 1.27 x 4.68 x 3.47 x 1.23 x 1.14 x 1 x 0.87 x
EV / EBITDA - -12.4 x -84.6 x -13.4 x -6.71 x -16.9 x -165 x 12.5 x
EV / FCF - - -32.2 x - - -10.3 x -14.3 x 607 x
FCF Yield - - -3.11% - - -9.72% -6.98% 0.16%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 4,304 4,304 7,639 7,639 8,403 9,240 - -
Reference price 2 1.510 1.510 3.820 2.720 1.060 0.9500 0.9500 0.9500
Announcement Date 08/06/20 26/04/21 07/04/22 29/04/23 01/05/24 - - -
1EUR in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3.487 5.132 6.235 5.99 7.245 8.005 9.065 10.49
EBITDA 1 - -0.522 -0.345 -1.547 -1.327 -0.54 -0.055 0.73
EBIT 1 - -0.819 -0.538 -1.787 -1.594 -0.83 -0.345 0.385
Operating Margin - -15.96% -8.63% -29.83% -22% -10.37% -3.81% 3.67%
Earnings before Tax (EBT) - - - - - - - -
Net income -1.031 - - - - - - -
Net margin -29.57% - - - - - - -
EPS - - - - - - - -
Free Cash Flow 1 - - -0.907 - - -0.885 -0.635 0.015
FCF margin - - -14.55% - - -11.06% -7% 0.14%
FCF Conversion (EBITDA) - - - - - - - 2.05%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 08/06/20 26/04/21 07/04/22 29/04/23 01/05/24 - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - -0.91 - - -0.89 -0.64 0.02
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - 0.27 - - 0.2 0.5 0.7
Capex / Sales - - 4.38% - - 2.5% 5.52% 6.67%
Announcement Date 08/06/20 26/04/21 07/04/22 29/04/23 01/05/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BIO-GATE AG Stock Bio-Gate AG
-10.38% 9.77M
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.03% 180B
MEDTRONIC PLC Stock Medtronic plc
-6.32% 99.21B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.15% 66.25B
DEXCOM, INC. Stock DexCom, Inc.
-10.62% 44.74B
CENCORA, INC. Stock Cencora, Inc.
+8.34% 43.82B
HOYA CORPORATION Stock Hoya Corporation
+10.35% 41.96B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+11.64% 28.98B
TERUMO CORPORATION Stock Terumo Corporation
+16.18% 24.07B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.87% 23.5B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. BIG1 Stock
  4. Financials Bio-Gate AG